Skip to main content
. 2021 Mar 13;268(9):3421–3434. doi: 10.1007/s00415-021-10504-x

Table 3.

Daily life mobility measures

Patients with ANOVA model
Healthy subjects Vestibular disorders Cerebellar disorders Functional disorders Hypokinetic disorders Vascular disorders Others All F(6, 365) p
Adherence
 Days recorded [d] 12.3 ± 1.9 12.2 ± 2.2 12.4 ± 1.2 12.1 ± 2.6 12.4 ± 1.3 11.8 ± 2.4 12.4 ± 1.4 12.3 ± 2.0 1.1 n.s
 Time sensor 'on' [%] 96 ± 12 96 ± 6 99 ± 6 95 ± 15 98 ± 4 96 ± 12 97 ± 9 97 ± 9 0.2 n.s
Volume
 Step count [#] 10,208 ± 3,299 8,316 ± 3,293* 6,305 ± 3,302* 8,251 ± 3,162* 4,949 ± 3,606* 8,696 ± 4,265* 7,545 ± 3,941* 7,981 ± 3761 9.5  < 0.001
 Ambulation time [%] 8.7 ± 2.6 7.4 ± 2.6* 5.7 ± 2.5* 7.3 ± 2.4* 4.4 ± 2.9* 7.7 ± 3.3 6.7 ± 3.1 7.0 ± 2.9 10.3  < 0.001
 Sedentary time [%] 27.8 ± 7.7 31.4 ± 8.9* 34.5 ± 10.2* 28.5 ± 8.2 37.6 ± 9.7* 26.6 ± 6.7 29.2 ± 7.9 30.6 ± 9.2 7.9  < 0.001
 Sleep time [%] 40.8 ± 6.7 40.9 ± 8.1 42.3 ± 9.9 43.8 ± 9.9* 41.8 ± 14.8 43.6 ± 10.7* 45.2 ± 11.6* 42.3 ± 9.5 1.1 n.s
Activity
 Ambulation bouts [#] 456 ± 134 413 ± 118 338 ± 139* 418 ± 133 247 ± 130* 439 ± 165 374 ± 174 396 ± 149 8.6  < 0.001
 Ambulatory bout duration [s] 17 ± 5 16 ± 4 15 ± 4 16 ± 4 15 ± 4 15 ± 4 16 ± 4 16 ± 4 1.9 n.s
 Daily intensity [MET] 35 ± 1 34 ± 1 33 ± 1* 34 ± 1 33 ± 2* 34 ± 2 34 ± 2 34 ± 2 10.2  < 0.001
Pattern
 Ambulation alpha 1.42 ± 0.04 1.43 ± 0.02 1.43 ± 0.04 1.42 ± 0.03 1.43 ± 0.03 1.43 ± 0.03 1.42 ± 0.02 1.42 ± 0.03 0.8 n.s
 Sit–walk transitions [#] 40 ± 16 39 ± 16 36 ± 13 38 ± 15 30 ± 12 38 ± 17 41 ± 23 38 ± 16 1.4 n.s

Results from the 14 day continuous mobility tracking in the different clinical subgroups and healthy subjects. Mobility parameters are arranged with respect to the physical activity domains volume, activity, and pattern

*Significant difference in the Sheffé post hoc comparison (compared to healthy subjects)